250 related articles for article (PubMed ID: 29778697)
1. Structural basis for selective inhibition of antibacterial target MraY, a membrane-bound enzyme involved in peptidoglycan synthesis.
Hering J; Dunevall E; Ek M; Brändén G
Drug Discov Today; 2018 Jul; 23(7):1426-1435. PubMed ID: 29778697
[TBL] [Abstract][Full Text] [Related]
2. Structural insights into inhibition of lipid I production in bacterial cell wall synthesis.
Chung BC; Mashalidis EH; Tanino T; Kim M; Matsuda A; Hong J; Ichikawa S; Lee SY
Nature; 2016 May; 533(7604):557-560. PubMed ID: 27088606
[TBL] [Abstract][Full Text] [Related]
3. Structures of Bacterial MraY and Human GPT Provide Insights into Rational Antibiotic Design.
Mashalidis EH; Lee SY
J Mol Biol; 2020 Aug; 432(18):4946-4963. PubMed ID: 32199982
[TBL] [Abstract][Full Text] [Related]
4. GlcNAc-1-P-transferase-tunicamycin complex structure reveals basis for inhibition of N-glycosylation.
Yoo J; Mashalidis EH; Kuk ACY; Yamamoto K; Kaeser B; Ichikawa S; Lee SY
Nat Struct Mol Biol; 2018 Mar; 25(3):217-224. PubMed ID: 29459785
[TBL] [Abstract][Full Text] [Related]
5. Natural Products at Work: Structural Insights into Inhibition of the Bacterial Membrane Protein MraY.
Koppermann S; Ducho C
Angew Chem Int Ed Engl; 2016 Sep; 55(39):11722-4. PubMed ID: 27511599
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and biological evaluation of a MraY selective analogue of tunicamycins.
Yamamoto K; Sato T; Hikiji Y; Katsuyama A; Matsumaru T; Yakushiji F; Yokota SI; Ichikawa S
Nucleosides Nucleotides Nucleic Acids; 2020; 39(1-3):349-364. PubMed ID: 31566068
[TBL] [Abstract][Full Text] [Related]
7. Exploring the Active Site of the Antibacterial Target MraY by Modified Tunicamycins.
Hering J; Dunevall E; Snijder A; Eriksson PO; Jackson MA; Hartman TM; Ting R; Chen H; Price NPJ; Brändén G; Ek M
ACS Chem Biol; 2020 Nov; 15(11):2885-2895. PubMed ID: 33164499
[TBL] [Abstract][Full Text] [Related]
8. Antibacterial Nucleoside Natural Products Inhibiting Phospho-MurNAc-Pentapeptide Translocase; Chemistry and Structure-Activity Relationship.
Ichikawa S; Yamaguchi M; Matsuda A
Curr Med Chem; 2015; 22(34):3951-79. PubMed ID: 26282943
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of phospho-MurNAc-pentapeptide translocase (MraY) by nucleoside natural product antibiotics, bacteriophage ϕX174 lysis protein E, and cationic antibacterial peptides.
Bugg TD; Rodolis MT; Mihalyi A; Jamshidi S
Bioorg Med Chem; 2016 Dec; 24(24):6340-6347. PubMed ID: 27021004
[TBL] [Abstract][Full Text] [Related]
10. Phospho-MurNAc-pentapeptide translocase (MraY) as a target for antibacterial agents and antibacterial proteins.
Bugg TD; Lloyd AJ; Roper DI
Infect Disord Drug Targets; 2006 Jun; 6(2):85-106. PubMed ID: 16789873
[TBL] [Abstract][Full Text] [Related]
11. [Bridge between Total Synthesis of Bioactive Natural Products and Development of Drug Leads].
Ichikawa S
Yakugaku Zasshi; 2022; 142(4):355-363. PubMed ID: 35370192
[TBL] [Abstract][Full Text] [Related]
12. Mechanism of action of nucleoside antibacterial natural product antibiotics.
Bugg TDH; Kerr RV
J Antibiot (Tokyo); 2019 Dec; 72(12):865-876. PubMed ID: 31471595
[TBL] [Abstract][Full Text] [Related]
13. MraY-antibiotic complex reveals details of tunicamycin mode of action.
Hakulinen JK; Hering J; Brändén G; Chen H; Snijder A; Ek M; Johansson P
Nat Chem Biol; 2017 Mar; 13(3):265-267. PubMed ID: 28068312
[TBL] [Abstract][Full Text] [Related]
14. Active site mapping of MraY, a member of the polyprenyl-phosphate N-acetylhexosamine 1-phosphate transferase superfamily, catalyzing the first membrane step of peptidoglycan biosynthesis.
Al-Dabbagh B; Henry X; El Ghachi M; Auger G; Blanot D; Parquet C; Mengin-Lecreulx D; Bouhss A
Biochemistry; 2008 Aug; 47(34):8919-28. PubMed ID: 18672909
[TBL] [Abstract][Full Text] [Related]
15. Catalytic mechanism of MraY and WecA, two paralogues of the polyprenyl-phosphate N-acetylhexosamine 1-phosphate transferase superfamily.
Al-Dabbagh B; Olatunji S; Crouvoisier M; El Ghachi M; Blanot D; Mengin-Lecreulx D; Bouhss A
Biochimie; 2016 Aug; 127():249-57. PubMed ID: 27312048
[TBL] [Abstract][Full Text] [Related]
16. Scintillation proximity assay for inhibitors of Escherichia coli MurG and, optionally, MraY.
Ravishankar S; Kumar VP; Chandrakala B; Jha RK; Solapure SM; de Sousa SM
Antimicrob Agents Chemother; 2005 Apr; 49(4):1410-8. PubMed ID: 15793120
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and evaluation of cyclopentane-based muraymycin analogs targeting MraY.
Kwak SH; Lim WY; Hao A; Mashalidis EH; Kwon DY; Jeong P; Kim MJ; Lee SY; Hong J
Eur J Med Chem; 2021 Apr; 215():113272. PubMed ID: 33607457
[TBL] [Abstract][Full Text] [Related]
18. Insights into the Target Interaction of Naturally Occurring Muraymycin Nucleoside Antibiotics.
Koppermann S; Cui Z; Fischer PD; Wang X; Ludwig J; Thorson JS; Van Lanen SG; Ducho C
ChemMedChem; 2018 Apr; 13(8):779-784. PubMed ID: 29438582
[TBL] [Abstract][Full Text] [Related]
19. Recent advances in antimicrobial nucleoside antibiotics targeting cell wall biosynthesis.
Kimura K; Bugg TD
Nat Prod Rep; 2003 Apr; 20(2):252-73. PubMed ID: 12735700
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and Medicinal Chemistry of Muraymycins, Nucleoside Antibiotics.
Katsuyama A; Ichikawa S
Chem Pharm Bull (Tokyo); 2018; 66(2):123-131. PubMed ID: 29386462
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
